Gene therapy company Tocagen prices offering at low end of range – MarketWatch
|
Gene therapy company Tocagen prices offering at low end of range
MarketWatch Tocagen Inc. TOCA, +0.00% a cancer-selective gene therapy company, said Thursday that it priced its initial public offering at $10 a share, at the low end of its expected range. The company sold 8.5 million shares to raise $85 million. Tocagen had … |
